NIH-funded research Sbir 2 grant

Understanding how natural compounds fight cancer

Official title: Assigning mode of action to phenotypically discovered anticancer leads.

Funded at Attagene, INC. · NIH-10932976 · Data updated 2026-11-12

This study is exploring how natural products might help treat cancer by looking at how they affect certain proteins in our bodies, which could lead to new and better treatments for cancer patients.

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionAttagene, INC.
NIH-funded
Lab location1 site (Research Triangle Park, United States)
Project startSeptember 21, 2023
Project endJuly 31, 2025
Funding year2024
Award (this year)$1,000,000
NIH project number5R44CA285062-02
Project IDNIH-10932976 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are patients with various types of cancer who may benefit from novel anticancer therapies.

Less likely to help

Patients who are not currently undergoing treatment for cancer or those with conditions unrelated to cancer may not benefit from this research.

What this research studies

This research focuses on identifying how natural products can be used as effective cancer treatments. By using advanced techniques, the team aims to uncover the mechanisms through which these compounds work, which is crucial for developing new drugs. The approach involves analyzing the activity of specific proteins that control gene expression in response to these compounds. This could lead to more efficient drug discovery processes and better-targeted therapies for cancer patients.

Why it matters

Potential benefit: If successful, this research could lead to the development of new and more effective cancer treatments derived from natural products.

How similar studies have gone: Previous research has shown promise in using natural products for cancer treatment, indicating that this approach could yield significant advancements.

Where this research is happening

  • Attagene, INC.
    Research Triangle Park, United States
    Active

Researchers

  • Principal investigator: Makarov, Sergei S — Attagene, INC.
  • Study coordinator: Makarov, Sergei S

Related research

Other NIH-funded projects on the same topics.

  • Two-tier bioactivity check for water safety

    A fast, two-step test system to flag polluted water and identify problem chemicals so community water sources stay safer for everyone.

    NIH research Attagene, INC. · Research Triangle Park, United States · NIH-11602346

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.